Search - tctmd.com

Displaying 1 - 20 of 62

Sort: Relevancy | Date

News Industry News

CellProthera announces positive Phase I/IIb data for ProtheraCytes® cell therapy in acute myocardial infarction

May 29, 2024

News Industry News

Miracor Medical’s PiCSO® System receives CE Mark

June 23, 2020

News Industry News

CeleCor Therapeutics Announces Positive First-in-Human Data of RUC-4, a Novel Subcutaneous Platelet GPIIb/IIIa Inhibitor, Presented at TCT 2019

September 25, 2019

News Industry News

Angel Medical Systems Inc. Assembles World-Class Medical Advisory Board

September 20, 2019

News Industry News

Miracor Medical Starts PiCSO-AMI-I Randomized Study in EU

July 25, 2019

News Industry News

FDA Approves Impella 5.0 and Impella LD Extended Duration of Use to 14 Days for Cardiogenic Shock Derived from AMI or Cardiomyopathy

May 13, 2019

News Industry News

PiCSO therapy reduces infarct size in STEMI patients. Miracor Medical announces new publication at EuroPCR

May 24, 2018

News Industry News

Cordis and Medinol Announce FDA Approval of the Innovative EluNIR Drug-Eluting Stent System

November 30, 2017

News Industry News

Study Results: Titaniam-nitride-oxide (TiNO) Coated Stent is Non-inferior to Bioabsorbable Polymer Everolimus-eluting Stent (EES), for Patients Presenting with Acute Coronary Syndrome (ACS)

August 26, 2017

News Industry News

Abiomed Announces First Patient Enrolled in STEMI DTU Feasibility Study

May 05, 2017

News Industry News TCT 2016

Study Finds No Long-Term Clinical Benefit to Routine Follow-Up Coronary Angiography After PCI

November 01, 2016

News Industry News TCT 2016

Dedicated Stent Study Conducted in Women and Minority Assesses Risks of Adverse Cardiovascular Events Following Coronary Stent Procedures

November 01, 2016

News Industry News

Angionetics' Generx® [Ad5FGF-4] Gene Therapy Biologic Receives FDA Clearance For U.S. Phase 3 Clinical Study As A New, Single Dose, Treatment For Coronary Artery Disease

September 12, 2016

News Industry News

FDA Approves New AGGRASTAT® Product Format

September 01, 2016

News Industry News

Medicure Files Application for New AGGRASTAT® Product Format

May 11, 2016

News Industry News

DalCor Randomizes First Patient in the DalGenE Phase 3 Cardiovascular Outcomes Trial

April 26, 2016

News Industry News

Meta-Analysis of AGGRASTAT® (Tirofiban HCl) Presented at CRT 2016 Conference

February 22, 2016

News Industry News

TherOx Enrolls First Patient in Study of Next-Generation Supersaturated Oxygen Therapy for AMI

February 17, 2016

News Industry News

Regeneron and Sanofi Announce 18,000-Patient ODYSSEY OUTCOMES Trial of Praluent® Injection Fully Enrolled

November 23, 2015

News Industry News

TherOx Receives FDA IDE Approval for Study of Next-Generation Supersaturated Oxygen Therapy for AMI

November 04, 2015

Advertisement

CellProthera announces positive Phase I/IIb data for ProtheraCytes® cell therapy in acute myocardial infarction

Miracor Medical’s PiCSO® System receives CE Mark

CeleCor Therapeutics Announces Positive First-in-Human Data of RUC-4, a Novel Subcutaneous Platelet GPIIb/IIIa Inhibitor, Presented at TCT 2019

Angel Medical Systems Inc. Assembles World-Class Medical Advisory Board

Miracor Medical Starts PiCSO-AMI-I Randomized Study in EU

FDA Approves Impella 5.0 and Impella LD Extended Duration of Use to 14 Days for Cardiogenic Shock Derived from AMI or Cardiomyopathy

PiCSO therapy reduces infarct size in STEMI patients. Miracor Medical announces new publication at EuroPCR

Cordis and Medinol Announce FDA Approval of the Innovative EluNIR Drug-Eluting Stent System

Study Results: Titaniam-nitride-oxide (TiNO) Coated Stent is Non-inferior to Bioabsorbable Polymer Everolimus-eluting Stent (EES), for Patients Presenting with Acute Coronary Syndrome (ACS)

Abiomed Announces First Patient Enrolled in STEMI DTU Feasibility Study

Study Finds No Long-Term Clinical Benefit to Routine Follow-Up Coronary Angiography After PCI

Dedicated Stent Study Conducted in Women and Minority Assesses Risks of Adverse Cardiovascular Events Following Coronary Stent Procedures

Angionetics' Generx® [Ad5FGF-4] Gene Therapy Biologic Receives FDA Clearance For U.S. Phase 3 Clinical Study As A New, Single Dose, Treatment For Coronary Artery Disease

FDA Approves New AGGRASTAT® Product Format

Medicure Files Application for New AGGRASTAT® Product Format

DalCor Randomizes First Patient in the DalGenE Phase 3 Cardiovascular Outcomes Trial

Meta-Analysis of AGGRASTAT® (Tirofiban HCl) Presented at CRT 2016 Conference

TherOx Enrolls First Patient in Study of Next-Generation Supersaturated Oxygen Therapy for AMI

Regeneron and Sanofi Announce 18,000-Patient ODYSSEY OUTCOMES Trial of Praluent® Injection Fully Enrolled

TherOx Receives FDA IDE Approval for Study of Next-Generation Supersaturated Oxygen Therapy for AMI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content